Menu

Immunocore Holdings plc IMCR

Full chart Compare
Set alert

Price alert · IMCR

All alert types
30.99 USD +2.59 (+9.12%)

At closeNov 6, 2026, 4:00 PM EST

30.99 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

29.15 Day range 31.28
27.50 52-week range 40.72
YTD
-10.72%
1 year
-1.90%

Revenue & Expenses

Other Income → Expenses: $38.42MExpenses → Selling, General & Admin: $165.41MExpenses → Research & Development: $274.87MExpenses → Interest Expense: $12.17MExpenses → Income Tax: $16.41MGross Profit → Expenses: $394.93MRevenue → Gross Profit: $394.93MRevenue → Cost of Revenue: $5.09MNet Loss → Expenses: $35.51MOther Income$38.42MGross Profit$394.93MNet Loss$35.51MCost of Revenue$5.09MExpenses$468.86MSelling, General & Admin$165.41MResearch & Development$274.87MInterest Expense$12.17MIncome Tax$16.41MRevenue$400.02M

Latest period ending Dec 31, 2025 · select a line to chart its full history

IMCR annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
400.02M310.20M249.43M174.36M36.48M
394.93M307.47M248.39M173.27M36.48M
-45.35M-70.46M-59.65M-51.71M-174.59M
-35.51M-51.09M-55.29M-52.54M-180.03M
-0.71-1.02-1.13-1.15-4.24
IMCR annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
467.71M455.73M442.63M402.47M297.36M
1.07B1.01B597.00M526.76M377.22M
686.24M648.79M228.16M187.86M162.78M
436.69M432.72M85.01M81.45M79.80M
381.03M360.72M368.84M338.90M214.43M
IMCR annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-10.71M26.06M2.94M-49.21M-143.11M
-16.34M-355.13M-5.42M-2.20M-1.28M
12.37M343.88M34.35M145.44M288.19M
-4.34M-5.13M-5.42M-2.20M-1.28M
-14.68M14.81M31.86M94.04M143.80M